Z-2881-2026 Class III Ongoing
FDA device recall Z-2881-2026 was initiated by Siemens Healthcare Diagnostics, Inc. on Jun 26, 2026 and is designated Class III. Reason for recall: out-of-specification sodium azide concentration in Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls Lot U2. While the assay results were not impacted, the overall health risk to lab… The recall status is ongoing. Affected quantity: 494 US; 114 OUS.
Recall details
- Product Type
- Devices
- Report Date
- Aug 12, 2026
- Initiation Date
- Jun 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 494 US; 114 OUS
Product description
Syva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219UL
Reason for recall
out-of-specification sodium azide concentration in Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls Lot U2. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is low, as exposure is limited by small volumes and a 0.2% post-reconstitution sodium azide concentration, with the worst outcome being mild skin or eye irritation and no serious harm anticipated.
Distribution pattern
Worldwide - US Nationwide distribution in the states CA, ID, IL, IN, MA, MS, NC, NM, NY, OH, OK, OR, PA, WA, and Northern Mariana Islands part of USA and the countries of Canada, South Africa, Brazil, Chile, Colombia.
Code information
UDI-DI 00842768014321 Lot U2
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2881-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026